Skip to main content
NCBI home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2008 Apr 10;30(9):511–516. doi: 10.1111/j.1748-5827.1989.tb01623.x

Acquired immune‐mediated myasthenia gravis in a cat

P A Cuddon 1
PMCID: PMC7166455

ABSTRACT

Acquired myasthenia gravis was diagnosed in a four‐year‐old castrated male Somali in which the presenting signs consisted of progressive lameness, weakness, generalised muscle tremors, an inability to blink and voice loss. Clinical testing with edrophonium chloride, electrophysiology, immunocytochemistry and serum immunological techniques confirmed the diagnosis of myasthenia gravis and proved its immune‐mediated nature. Clinical remission was achieved following long term immunosuppression with corticosteroids.

REFERENCES

  1. Aquilonius, S. M. , Eckernas, S. A. , Hartvig, P. , Lindstrom, B. & Osterman, P. O. (1980) Pharmacokinetics and oral bioavailability of pyridostigmine in man. European Journal of Clinical Pharmacology 18, 423–428. [DOI] [PubMed] [Google Scholar]
  2. Bloch, R. J. & Stallcup, W. B. (1979) Agonist action of neostigmine on acetylcholine receptors of cultured mammalian muscle. Brain Research 172, 378–381. [DOI] [PubMed] [Google Scholar]
  3. Brunner, N. G. , Beiger, C. L. , Namba, T. & Grob, D. (1976) Corticotrophin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management. Annals of the New York Academy of Science 274, 577–595. [DOI] [PubMed] [Google Scholar]
  4. Dawson, J. R. B. (1970) Myasthenia gravis in a cat. Veterinary Record 86, 562–563. [DOI] [PubMed] [Google Scholar]
  5. Drachman, D. B. (1978) Myasthenia gravis. The New England Journal of Medicine 298, 136–142, 186–192. [DOI] [PubMed] [Google Scholar]
  6. Engel, A. G. , Lambert, E. H. & Santa, T. (1973) Study of long‐term anticholinesterase therapy: effects on neuromuscular transmission and on motor end‐plate fine structure. Neurology 23, 1273–1281. [DOI] [PubMed] [Google Scholar]
  7. Engel, A. G. , Lambert, E. H. & Howard, Jr F. M. (1977) Immune complexes (IgG and C3) at the motor end‐plate in myasthenia gravis. Mayo Clinic Proceedings 52, 267–280. [PubMed] [Google Scholar]
  8. Engel, A. G. (1984) Myasthenia gravis and myasthenic syndromes. Annals of Neurology 16, 519–534. [DOI] [PubMed] [Google Scholar]
  9. Engel, W. K. (1976) Myasthenia gravis, corticosteroids, anticholinesterases. Annals of the New York Academy of Science 274, 623–630. [DOI] [PubMed] [Google Scholar]
  10. Goudswaard, J. , Van Der Donk, J. A. , Noordzij, A. , van Dam, R. H. & Vaerman, J. P. (1978) Protein A reactivity of various mammalian immunoglobulins. Scandinavian Journal of Immunology 8, 21–28. [DOI] [PubMed] [Google Scholar]
  11. Hall, E. D. , Riker, W. F. & Baker, T. (1977) Glucocorticoid effects on the edrophonium responsiveness of normal and degenerating mammalian motor nerve terminals. Annals of Neurology 2, 404–408. [DOI] [PubMed] [Google Scholar]
  12. Indrieri, R. J. , Creighton, S. R. , Lambert, E. H. & Lennon, V. A. (1983) Myasthenia gravis in two cats. Journal of the American Veterinary Medical Association 182, 57–60. [PubMed] [Google Scholar]
  13. Joseph, R. J. , Carrillo, J. M. & Lennon, V. A. (1988) Myasthenia gravis in the cat. Journal of Veterinary Internal Medicine 2, 75–79. [DOI] [PubMed] [Google Scholar]
  14. Kao, I. & Drachman, D. B. (1977) Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Neurology (Minneapolis) 27, 364–365. [DOI] [PubMed] [Google Scholar]
  15. Kelly, M. J. (1981) Myasthenia gravis ‐ a receptor disease. Compendium on Continuing Education for the Practicing Veterinarian 3, 544–553. [Google Scholar]
  16. Lennon, V. A. , Palmer, A. C. , Pflugfelder, C. & Indrieri, R. J. (1978) Myasthenia gravis in dogs: acetylcholine receptor deficiency with and without anti‐receptor autoantibodies In: Genetic Control of Autoimmune Disease, Vol 1 Eds Rose N. R., Bigazzi P. E. and Warner N. L. Elsevier, North Holland , pp 295–306. [Google Scholar]
  17. Lindstrom, J. M. , Seybold, M. E. , Lennon, V. A. , Wittingham, S. & Duane, D. D. (1976) Antibody to acetylcholine receptor in myasthenia gravis. Neurology (Minneapolis) 26, 1054–1059. [DOI] [PubMed] [Google Scholar]
  18. Maddison, J. E. , Waelchli‐Suter, C. M. & Johnson, R. P. (1984) Clinical remission after corticosteroid therapy of acquired myasthenia in three dogs. Journal of the American Veterinary Medical Association 184, 845–848. [PubMed] [Google Scholar]
  19. Mason, K. V. (1976) A case of myasthenia gravis in a cat. Journal of Small Animal Practice 17, 467–472. [DOI] [PubMed] [Google Scholar]
  20. Pascuzzi, R. M. , Coslett, H. B. & Johns, T. R. (1984) Long‐term corticosteroid treatment of myasthenia gravis: report of 116 patients. Annals of Neurology 15, 291–298. [DOI] [PubMed] [Google Scholar]
  21. Pflugfelder, C. M. , Cardinet, G. H. , Lutz, H. , Holliday, T. A. & Hansen, R. J. (1981) Acquired canine myasthenia gravis: immunocytochemical localization of immune complexes at neuromuscular junctions. Muscle and Nerve 4, 289–295. [DOI] [PubMed] [Google Scholar]
  22. Riggs, J. E. (1982) Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis. Clinical Neuropharmacology 5. Raven Press, New York , pp 277–292. [DOI] [PubMed] [Google Scholar]
  23. Roberts, D. V. & Thesleff, S. (1969) Acetylcholine release from motor‐nerve endings in rats treated with neostigmine. European Journal of Pharmacology 6, 281–285. [DOI] [PubMed] [Google Scholar]
  24. Schwartz, B. D. (1984) The human major histocompatibility complex In: Basic and Clinical Immunology. 5th edn Eds Stites D. P., Stobo J. D., Fudenberg H. H. and Wells J. V. Lange Medical Publications, Los Altos , California , pp 55–68. [Google Scholar]
  25. Sveigaard, A. , Platz, P. & Ryder, L. P. (1983) HLA and disease 1982 ‐ A review. Immunological Reviews 70, 193–218. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Small Animal Practice are provided here courtesy of Wiley

RESOURCES